Oncomatryx Biopharma
Drug development, Tumour stroma, Cancer diagnosis, Immunoconjugates (ADCs).
Drug development, Tumour stroma, Cancer diagnosis, Immunoconjugates (ADCs).
Biomarkers, Diagnostics, Monitoring, Cancer, Autoimmune diseases, Inflammation, Protein-protein interactions, Post-translational modifications
Digital transformation, Analytics, Innovation, Cloud Computing, Hybrid IT, Mobility, Cybersecurity, Outsourcing, SAP, Microsoft, Blockchain, AI, Quantum Computing, Electronic Health Records, Digital health
Zebrafish, Alternative Models, R&D Process, Preclinical Research, Toxicity Screening, Toxicity Assays, Efficacy Assays, 3 Rs Animal Research.
Cell lines, Culture media, Drug screening, GPCRs, Biosensors, Neurodegenerative diseases.
Clean rooms, White Rooms, Controlled environment areas, Technological areas, Construction, Equipment, GMP, Classified area, Containment, Biosafety, ISO 14644, Adaptation of spaces, Adaptation to the real needs of the customer, Customised projects, Absolute confidentiality, Processing and advice regarding the Spanish Agency for Medicines and Medical Devices (AEMPS), the EMA and FDA.
Public Administrations, Competitiveness, Technology, R&D, Innovation, Entrepreneurship, Grants, Basque Government
Software, Quality, Consultancy, Testing, Training, Safety-critical systems, Verification and validation, Test automation.
Vocal biomarkers, Disease detection, Disease monitoring, Dementia, Cognitive impairment, Depression, Artificial intelligence, Telemedicine.
Male urinary incontinence, Medical devices, Urinary clamp, Urine leakage.